Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Gregory C. Jones"'
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-4 (2023)
A 20-year-old South Asian male presented with polyuria, polydipsia, HbA1c 81 mmol/mol, BMI 28.8 and family history of both type 1 and type 2 diabetes mellitus. As autoantibody testing was negative and c-peptide level demonstrated significant endogeno
Externí odkaz:
https://doaj.org/article/a52eb5d7bd63452996cd135e3e7d7794
Autor:
Hannah L. Barker, Deborah Morrison, Andrea Llano, Christopher A. R. Sainsbury, Gregory C. Jones
Publikováno v:
Diabetes Therapy. 14:937-945
Autor:
Stephen J. Cleland, Christine Skivington, Christopher Sainsbury, Marie Robertson, Gregory C. Jones
Publikováno v:
Diabetes. 69
Aims: The aims of this study were (a) to demonstrate that analyses of glucometer data/metadata can reveal real-time ward-level patient-centred outcomes relevant to hypoglycemia (b) to test whether a 6-month education and mentoring intervention improv
Publikováno v:
Diabetic Medicine. 35:745-749
Aims: Previous evidence has demonstrated that participation in the Dose Adjustment for Normal Eating (DAFNE) education programme can reduce HbA1c and severe hypoglycaemia in people with Type 1 diabetes. In a number of studies, increased HbA1c variabi
Publikováno v:
Diabetes, Obesity and Metabolism. 20:1014-1017
Aim: To investigate the relationship between variability in both visit‐to‐visit HbA1c and SBP and mortality in individuals with type 1 diabetes. Methods: The Scottish Care Information (SCI) Diabetes dataset was used to identify 5952 individuals w
Publikováno v:
Diabetic Medicine. 34:1541-1545
Aim: Despite evidence of morbidity, no evidence exists on the relationship between HbA1c variability and mortality in Type 1 diabetes. We performed an observational study to investigate whether the association between HbA1c variability and mortality
Publikováno v:
Diabetes Therapy
C-peptide is a widely used measure of pancreatic beta cell function. It is produced in equimolar amounts to endogenous insulin but is excreted at a more constant rate over a longer time. Methods of estimation include urinary and unstimulated and stim
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Diabetes Therapy
Cystic fibrosis is a common genetic condition and abnormal glucose handling leading to cystic fibrosis-related diabetes (CFRD) is a frequent comorbidity. CFRD is mainly thought to be the result of progressive pancreatic damage resulting in beta cell